'Life sciences, genomics and biotechnology for health' call for SMEs

The European Commission has published a call for proposals dedicated to SMEs under the 'Life sciences, genomics and biotechnology for health' section of the Sixth Framework Programme (FP6).

The call covers the following areas:
- rational and accelerated development of new, safer, more effective drugs, including pharmacogenomics approaches;
- development of new diagnostics;
- development of new in-vitro tests to replace animal experimentation;
- development and testing of new preventative and therapeutic tools, such as somatic gene and cell therapies and immunotherapies;
- innovative research in post-genomics;
- combating cardiovascular disease, diabetes and rare disorders;
- combating resistance to antibiotics and other drugs;
- studying the brain and combating diseases of the nervous system;
- studying human development and the ageing process.

To see the full details of the call, please consult the following web address:
http://fp6.cordis.lu/lifescihealth/call_details.cfm?CALL_ID=214

Remarks: The deadline for submitting proposal documents is 9.11.2005.

Before contacting the Commission, proposers are strongly advised to consult the original call text in the Official Journal of the European Union at the reference below.

Data Source Provider: Official Journal of the European Union
Document Reference: OJ No C 168 of 8.7.2005, p.61
Programme or Service Acronym: FRAMEWORK 6C; FP6-INTEGRATING; FP6-LIFESCIHEALTH

Topic: Biotechnology, Health and Medicine

The initiative The topics The regions The networks The service press releases Order Service newsletter subscription news announcements patents Events Event Review ICT Cluster Monitor	News
	'Life sciences, genomics and biotechnology for health' call for SMEs The European Commission has published a call for proposals dedicated to SMEs under the 'Life sciences, genomics and biotechnology for health' section of the Sixth Framework Programme (FP6). The call covers the following areas: - rational and accelerated development of new, safer, more effective drugs, including pharmacogenomics approaches; - development of new diagnostics; - development of new in-vitro tests to replace animal experimentation; - development and testing of new preventative and therapeutic tools, such as somatic gene and cell therapies and immunotherapies; - innovative research in post-genomics; - combating cardiovascular disease, diabetes and rare disorders; - combating resistance to antibiotics and other drugs; - studying the brain and combating diseases of the nervous system; - studying human development and the ageing process. To see the full details of the call, please consult the following web address: http://fp6.cordis.lu/lifescihealth/call_details.cfm?CALL_ID=214 Remarks: The deadline for submitting proposal documents is 9.11.2005. Before contacting the Commission, proposers are strongly advised to consult the original call text in the Official Journal of the European Union at the reference below. Data Source Provider: Official Journal of the European Union Document Reference: OJ No C 168 of 8.7.2005, p.61 Programme or Service Acronym: FRAMEWORK 6C; FP6-INTEGRATING; FP6-LIFESCIHEALTH Topic: Biotechnology, Health and Medicine	Print page Back